In conclusion, our study firstly highlights the deleterious role of IL-19 on development of pulmonary fibrosis by modulating fibroblasts through TGF-β/Smad pathway and reinforces its promise as a new therapeutic target for intervention in pulmonary fibrosis. This evidence concerns the gene IL19 and pulmonary fibrosis.